World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
36216
World Ranking
10785
National Ranking
5548

Donald L. Trump publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Donald L. Trump sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 464 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Donald L. Trump D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Donald L. Trump sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Donald L. Trump is affiliated with the University of Virginia in the United States. Their research primarily focuses on Medicine and Biochemistry, Genetics and Molecular Biology, with notable contributions in several subfields such as Pulmonary and Respiratory Medicine, Genetics, Radiology, Nuclear Medicine and Imaging, Surgery, and Economics and Econometrics.

Their work spans multiple topics including Advances in Oncology and Radiotherapy, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, Vitamin D Research Studies, Economic and Financial Impacts of Cancer, BRCA gene mutations in cancer, and Urinary Tract Infections Management.

Donald L. Trump has contributed to journal articles and book publications. The book titled Centers of the Cancer Universe was published in 2021 by Rowman & Littlefield.

Recent papers highlight various research areas:

  • Studying the urine microbiome in superficial bladder cancer: samples obtained by midstream voiding versus cystoscopy, 2020, BMC Urology
  • Impact of neoadjuvant chemotherapy on survival and recurrence patterns after robot-assisted radical cystectomy for muscle-invasive bladder cancer: Results from the International Robotic Cystectomy Consortium, 2021, International Journal of Urology
  • Patient attendance at molecular tumor board: A new means of shared decision making?, 2022, Current Problems in Cancer
  • A Rare Variant in ERF (rs144812092) Predisposes to Prostate and Bladder Cancers in an Extended Pedigree, 2021, Cancers
  • Abstract 6540: Regression of metastatic cancer and abscopal effects following in situ vaccination by cryosurgical tumor cell lysis and intratumoral immunotherapy: A case series, 2020, Cancer Research

Frequent co-authors collaborating with Donald L. Trump include:

  • Eric T. Rosenthal
  • Éric Rosenthal
  • James L. Mohler
  • Jeannette T. Bensen
  • Candace S. Johnson

Most publications appear in venues such as:

  • UNC Libraries
  • BMC Urology
  • International Journal of Urology
  • Current Problems in Cancer
  • Cancers

Best Publications

  • Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

    H. Barton Grossman;Ronald B. Natale;Catherine M. Tangen;V.O. Speights

  • Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

    Kristin K. Deeb;Donald L. Trump;Candace S. Johnson

  • Hypersensitivity reactions from taxol.

    R B Weiss;R C Donehower;P H Wiernik;T Ohnuma

  • Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.

    E M Messing;J Manola;M Sarosdy;G Wilding

  • Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

    Glenn J. Bubley;Michael Carducci;William Dahut;Nancy Dawson

  • Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study

    Philip W. Kantoff;Susan Halabi;Mark Conaway;Joel Picus

  • Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

    Edward M Messing;Judith Manola;Jorge Yao;Maureen Kiernan

  • Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

    S B Saxman;K J Propert;L H Einhorn;E D Crawford

  • An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.

    K Antman;J Crowley;S P Balcerzak;S E Rivkin

  • The Role of Vitamin D in Cancer Prevention and Treatment

    Aruna V. Krishnan;Donald L. Trump;Candace S. Johnson;David Feldman

  • Trastuzumab, Paclitaxel, Carboplatin, and Gemcitabine in Advanced Human Epidermal Growth Factor Receptor-2/neu–Positive Urothelial Carcinoma: Results of a Multicenter Phase II National Cancer Institute Trial

    Maha H.A. Hussain;Gary R. MacVicar;Daniel P. Petrylak;Rodney L. Dunn

  • Bone Loss after Initiation of Androgen Deprivation Therapy in Patients with Prostate Cancer

    Susan L. Greenspan;Penelope Coates;Susan M. Sereika;Joel B. Nelson

  • Prognostic Factors for Survival in Patients with Recurrent or Metastatic Renal Cell Carcinoma

    Paul J. Elson;Robert S. Witte;Donald L. Trump

  • Sulforaphane-induced Cell Death in Human Prostate Cancer Cells Is Initiated by Reactive Oxygen Species

    Shivendra V. Singh;Sanjay K. Srivastava;Sunga Choi;Karen L. Lew

  • Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.

    S. A. Grossman;D. M. Finkelstein;J. C. Ruckdeschel;D. L. Trump

  • Bladder cancer. Clinical practice guidelines in oncology.

    Peter E. Clark;Neeraj Agarwal;Matthew C. Biagioli;Mario A. Eisenberger

  • Phase III Study of Interferon Alfa-NL as Adjuvant Treatment for Resectable Renal Cell Carcinoma: An Eastern Cooperative Oncology Group/Intergroup Trial

    Edward M. Messing;Judith Manola;George Wilding;Kathleen Propert

  • Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis.

    Dong Xiao;Sanjay K. Srivastava;Karen L. Lew;Yan Zeng

  • Effect of Once-Weekly Oral Alendronate on Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Randomized Trial

    Susan L. Greenspan;Joel B. Nelson;Donald L. Trump;Neil M. Resnick

  • Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2.

    Dong Xiao;Sunga Choi;Daniel E Johnson;Victor G Vogel

Frequent Co-Authors

Candace S. Johnson
Candace S. Johnson Roswell Park Cancer Institute
Carl Morrison
Carl Morrison Roswell Park Cancer Institute
James L. Mohler
James L. Mohler Roswell Park Cancer Institute
Edward M. Messing
Edward M. Messing University of Rochester Medical Center
Nicholas J. Vogelzang
Nicholas J. Vogelzang University of Nevada Reno
Chandra P. Belani
Chandra P. Belani Penn State Cancer Institute
Adam R. Karpf
Adam R. Karpf University of Nebraska Medical Center
E. David Crawford
E. David Crawford University of California, San Diego
Badrinath R. Konety
Badrinath R. Konety University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online degrees is a smart way to advance your healthcare career, especially if you’re considering studying Medicine in the USA. For nurses looking to become family nurse practitioners, the asn to fnp pathway offers a direct bridge from an associate degree to a master’s qualification.

If your interest lies more in preventive health and wellness, an online bs in nutrition provides a flexible route towards a career in dietetics and nutritional science. For those aiming for administrative and leadership roles in healthcare, consider online mha programs cahme accredited to ensure you have a respected and comprehensive education in healthcare management.

Finally, registered nurses seeking advancement can benefit from an rn to bsn online with no clinicals program, allowing for career growth without additional hands-on clinical requirements.

Best Scientists Citing Donald L. Trump

Trending Scientists

Recently Published Articles